Abstract:Nrf2 is a key transcription factor that regulates redox status by up‐regulating antioxidant genes. Previous data from our laboratory demonstrated that increased ROS in the RVLM contributed to the sympatho‐excitation in rabbits with chronic heart failure. Accordingly, we hypothesized that deletion of Nrf2 in the RVLM of mice will increase sympathetic drive due to oxidative stress by down‐regulating antioxidant protein expression. Twenty seven Nrf2 Floxed mice were randomized into two groups: control mice received Lenti‐GFP microinjection into bilateral RVLM, while Nrf2‐deleted mice received Lenti‐Cre‐GFP. Real‐time RT‐PCR, Western blot analysis, immunofluorescence, DHE staining, and ELISA were used to evaluate mRNA level, protein expression, ROS production, and NE concentration. Blood pressure in the conscious state was measured by the radiotelemetry. Renal sympathetic nerve activity (RSNA) was recorded under anesthesia. We found that (1) Nrf2 mRNA and protein levels in the RVLM of Cre‐mice were significantly lower than GFP‐mice (mRNA: 0.3 ± 0.1 vs 1.0 ± 0.1; protein: 0.07 ± 0.02 vs 0.32 ± 0.03. **P < 0.01, n = 6). The down‐regulated Nrf2 protein in the RVLM of Cre‐mice was further confirmed by immunofluorescence staining, where the Lenti‐Cre‐GFP positive neurons exhibited a markedly decreased Nrf2 protein compared to the adjacent negative neurons. (2) The expression of principle antioxidant proteins targeted by Nrf2, including NQO1, HO1, SOD2, and Catalase, were significantly lower in the RVLM of Cre‐mice (HO1: 0.93 ± 0.10 vs 1.27 ± 0.12; NQO1: 0.57 ± 0.08 vs 0.93 ± 0.12; SOD2: 0.46 ± 0.10 vs 1.68 ± 0.14; Catalase: 0.34 ± 0.13 vs 1.11 ± 0.20; *P < 0.05, n = 6). Consistent with the change in antioxidant protein expression, the superoxide level in the Lenti‐Cre‐GFP positive neurons was significantly increased (arbitrary DHE signal: 71.8 ± 2.95 vs 39.2 ± 0.67; *P < 0.05, n = 10 and 12). (3) In the conscious state, Cre‐mice displayed a significant increase in blood pressure compared to GFP‐mice (24h averaged MAP: 123.7 ± 3.8 vs 100.2 ± 2.2 mm Hg, *p < 0.05, n = 6). In addition, Cre‐mice had significantly elevated urinary NE concentration (456.4 ± 16.9 vs 356.5 ± 19.9 ng/mL, *P < 0.05, n = 13–14) and 24‐hour NE excretion (676.5 ± 64.1 vs 416.5 ± 28.1 ng, *P < 0.05, n = 13–14), and decreased spontaneous baroreflex gain (Up‐sequence: 1.66 ± 0.17 vs 3.61 ± 0.22 ms/mm Hg, *P < 0.05, n = 6; Down‐sequence: 1.89 ± 0.12 vs 2.98 ± 0.19 ms/mmHg, *P < 0.05, n = 6) as compared to GFP‐mice. (4) Under anesthesia, Cre‐mice displayed elevated baseline RSNA (63.75 ± 8.1 vs 24.21 ± 4.3 %/Max, *P < 0.05, n = 5) and impaired inducible baroreflex function (Ave Slope: 0.08 ± 0.01 vs 0.13 ± 0.02 %mmHg; Gain Max: 1.64 ± 0.2 vs 3.46 ± 0.2 %mmHg; Minimum RSNA: 8.98 ± 1.21 vs 46.32 ± 5.51 %/Max; PB50: 122.34 ± 8.9 vs 90.13 ± 11.5 mmHg; Range of RSNA Response: 79.9 ± 9.8 vs 107.4 ± 12.4 %/Max, *P < 0.05, n = 5–6). Based on the above data, we conclude that selective Nrf2 gene deletion in the RVLM elevates blood pressure, increases sympathetic outflow, and impairs baroreflex function potentially by the oxidative stress due to the impaired antioxidant mechanisms. Supported by NIH grant P01‐HL62222

Abstract 399: Whole-Body Deletion of PPAR? in Mice Increases Sympathetic Nerve Activity

Abstract 085: Loss of Microglia Enhances Neuronal Activity in the Sympathetic Paraventricular Nucleus

Selective Nrf2 Gene Deletion in the RVLM Increases Blood Pressure and Evokes Sympatho‐Excitation in Mice

Systemic PPARγ Deletion Impairs Circadian Rhythms of Behavior and Metabolism

Differential Contribution of POMC and AgRP Neurons to the Regulation of Regional Autonomic Nerve Activity by Leptin.

Nervous System Expression of PPARγ and Mutant PPARγ Has Profound Effects on Metabolic Regulation and Brain Development.

Abstract P074: Role of Peroxisome Proliferator-Activated Receptor-γ (PPAR) in the Pro-opiomelanocortin (POMC) Neuron-Mediated Regulation of Energy Balance

Distal Convoluted Tubule-Specific Deletion of Specific Deletion of (pro)renin Receptor in Mice Increases Energy Expenditure and Enhances Aggressiveness

Effect of Selective Expression of Dominant-Negative PPARγ in Pro-Opiomelanocortin Neurons on the Control of Energy Balance.

Cardiomyocyte-Restricted Ppar Delta Deletion in Ppar Alpha Null Mice Leads to Cardiac Hypertrophy and Heart Failure

Abstract 003: Mrap2 Dissociate Mc4r-Mediated Sympathetic Control of Metabolism and Blood Pressure

Mutation in the PPARγ Ligand Binding Domain Impairs the Anti‐inflammatory Action of PPARγ

Conditional PPARγ Knockout from Cardiomyocytes of Adult Mice Impairs Myocardial Fatty Acid Utilization and Cardiac Function.

Abstract 124: RhoBTB1, a Novel PPARγ Target Gene, Rescues Hypertension and Vascular Dysfunction Caused by PPARγ Dysfunction

Selective Nrf2 Gene Deletion in the Rostral Ventrolateral Medulla Evokes Hypertension and Sympathoexcitation in Mice.

Hypertension-Causing Mutation in Peroxisome Proliferator–Activated Receptor Γ Impairs Nuclear Export of Nuclear Factor-κB P65 in Vascular Smooth Muscle

Hypotension, lipodystrophy, and insulin resistance in generalized PPARgamma-deficient mice rescued from embryonic lethality.

Cardiomyopathy and Worsened Ischemic Heart Failure in SM22-α Cre-Mediated Neuropilin-1 Null Mice: Dysregulation of PGC1α and Mitochondrial Homeostasis.

Cardiomyopathy and Worsened Ischemic Heart Failure in SM22-α Cre-Mediated Neuropilin-1 Null Mice

Enhancing natriuretic peptide signaling in adipose tissue, but not in muscle, protects against diet-induced obesity and insulin resistance.

Hypotension, lipodystrophy, and insulin resistance in generalized PPARγ-deficient mice rescued from embryonic lethality